Rolf Ljung

Has grant

Professor

Lund University Medical Faculty Foundation

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Medical Science Medical Science professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Rolf Ljung is a Professor at Lund University Medical Faculty Foundation in Sweden. His research areas primarily focus on haemophilia management, with recent contributions to the long-term safety and efficacy of treatments for severe haemophilia A and B. Additionally, he has conducted studies on the natural history of haemophilia and the implementation of prophylaxis in pediatric populations. His work also explores innovative therapies, including autologous cell therapy and the evaluation of prophylactic treatment regimens using advanced imaging technologies.

Recent Grants

Grant: Close

Hemophilia Molecular and Clinical Studies

Open Date:

Close Date:

Articles (12)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (2)

Andrea S. Doria

CANADA

View details

Marcus Fager Ferrari

Lund University

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rolf Ljung

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (12)

BAY 81‐8973 Demonstrates Long‐Term Safety and Efficacy in Children With Severe Haemophilia A: Results From the LEOPOLD Kids Extension Study

Hemophilia B Leyden: characteristics and natural history in the International Pediatric Network of Hemophilia Management Registry

International Prophylaxis Study Group (IPSG) haemophilia joint MRI scale version 2.0

Origin of pathogenic variant and mosaicism in families with a sporadic case of haemophilia B

Recombinant factor IX Fc for the treatment of hemophilia B

Primary prophylaxis in children with severe haemophilia A and B—Implementation over the last 20 years as illustrated in real‐world data in the PedNet cohorts

Haemophilia A and B – evaluation of the Swedish prophylactic regimen by magnetic resonance imaging

Autologous cell therapy – A new concept to eradicate inhibitors in haemophilia

Identification of F8 rearrangements in carrier and non‐carrier mothers of haemophilia A patients

Practical considerations for nonfactor‐replacement therapies in the treatment of haemophilia with inhibitors

Registries and databases—A European perspective

Genetic screening of children with suspected inherited bleeding disorders

Collaborators (2)

Andrea S. Doria

Marcus Fager Ferrari

Make your next move.